FDA authorises Abbott’s Libre Duo dual glucose-ketone sensor
Abbott's Libre Duo 10 Day wins FDA authorisation as the first dual glucose-ketone sensor, opening a new front in diabetes-tech competition.
Markets
Delayed · 00:33 UK
Section
The latest banking and finance news and analysis from the Financial News newsroom.
411–420 of 1,499
Abbott's Libre Duo 10 Day wins FDA authorisation as the first dual glucose-ketone sensor, opening a new front in diabetes-tech competition.
Boston Scientific cyberattack disrupts global order processing and shipping; shares fall as investigation into the breach continues.
McKesson's Precision Medicine Group acquisition, worth ~$2.25bn, deepens its push into oncology and specialty services, filings show.
Lloyds Banking Group half-year profit rose to £4.3bn in the six months to 30 June, up from £3.5bn a year earlier, as the bank lifted its interim dividend by 30%…
OpenAI's data centers chief Chris Malone has left the company, the latest in a run of senior exits ahead of a planned 2027 listing.
Canada retaliatory tariffs of up to 50% hit $20bn of US goods from 8 September, matching Washington's levies dollar-for-dollar.
The Greggs interim results 2026 sent the baker's shares up 16.1% on 29 July, extending a two-day gain to roughly 23.4% since Monday morning's open. A £5,000 position taken at…
Dick's Sporting Goods stock plunge wiped a quarter of its value after a $31.9m Foot Locker loss and a cut to full-year profit guidance.
The Grant Thornton CBIZ deal, announced on 29 July 2026, will hand shareholders of the New York-listed management consultancy $55 per share in cash, a 54 per cent premium to…
Private credit has become one of the fastest-growing segments of alternative finance globally, and business leaders across emerging markets are starting to take notice. According to Moody's, assets under management…
Page 42 of 150